Artwork

Content provided by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Introduction to Targeted Therapies: Monoclonal Antibodies

3:32
 
Share
 

Manage episode 429143456 series 2993668
Content provided by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Send us a text

Introduction to Targeted Therapies: Monoclonal Antibodies

Targeted Therapy is the foundation of Precision Medicine. Targeted therapy is a type of personalized treatment that targets specific proteins that control how cells grow, divide, and spread.

Antibodies are produced naturally by our body and help the immune system recognize cells that cause disease, such as bacteria and viruses, and mark them for destruction. Antibodies can be engineered in the laboratory to find and attach themselves to specific targets, called antigens, found on cancer cells. They are made to recognize and bind only to a very specific antigen target.

This week's episode highlights three important terms you may be hearing: Antibody-Drug Conjugates, Monoclonal Antibodies, and Bispecific Antibodies.
You can download the full Executive Briefing at: https://tkgpact.com/executive-briefings/

Or, feel free to email us at [email protected]

  continue reading

63 episodes

Artwork
iconShare
 
Manage episode 429143456 series 2993668
Content provided by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Send us a text

Introduction to Targeted Therapies: Monoclonal Antibodies

Targeted Therapy is the foundation of Precision Medicine. Targeted therapy is a type of personalized treatment that targets specific proteins that control how cells grow, divide, and spread.

Antibodies are produced naturally by our body and help the immune system recognize cells that cause disease, such as bacteria and viruses, and mark them for destruction. Antibodies can be engineered in the laboratory to find and attach themselves to specific targets, called antigens, found on cancer cells. They are made to recognize and bind only to a very specific antigen target.

This week's episode highlights three important terms you may be hearing: Antibody-Drug Conjugates, Monoclonal Antibodies, and Bispecific Antibodies.
You can download the full Executive Briefing at: https://tkgpact.com/executive-briefings/

Or, feel free to email us at [email protected]

  continue reading

63 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play